Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPharmacielo Ltd

Pharmacielo Ltd

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.05 CAD -0.01 ( 9.09%)
Last update at 2026-11-05T18:00:00Z
VOLUME
1000
Market Cap
10.34M

Momentum Score

…

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.05
Low
0.05
High
52 Week Price Range
0.04
Low
0.17
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Pharmacielo Ltd is a Canadian-listed small-cap company that, based on public disclosures, develops and seeks to commercialize cannabinoid-derived pharmaceutical products and related formulations. Long-term growth drivers may include regulatory approvals, pipeline advancement and expansion into reimbursed markets, and investors may find the company attractive for exposure to therapeutic cannabis development with potential commercial upside.

The main investment risks are regulatory and clinical trial uncertainty, limited public financial disclosure with probable ongoing financing needs, and low trading liquidity.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.06
Dividend Yield
-
Revenue TTM
1.75M
Revenue Per Share
0.01
Gross Profit TTM
-0.31M
Debt / Equity
-
ROE
-3013.15%
Net Debt
20.38M
ROCE
172.64%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -9.14M -16.30M -14.52M -26.63M -43.76M
Net income -9.14M -16.30M -14.52M -26.63M -43.76M
Selling general administrative 5.42M 8.31M 11.48M 19.15M 32.60M
Gross profit 0.73M -1.37M 0.83M -4.31M -6.64M
Reconciled depreciation 1.27M 1.41M 1.58M 1.26M 1.57M
Ebit - - - -25.06M -32.85M
Ebitda - - -11.40M -24.75M -41.92M
Operating income -4.90M -10.04M -11.43M -25.19M -43.42M
Other operating expenses - - - - 0.02M
Interest expense 3.27M 2.69M 1.54M 0.56M 0.27M
Interest income 0.00M 0.00M 0.00M 0.00M 0.07M
Net interest income -3.44M -2.86M -1.59M -0.56M -0.21M
Total revenue 3.48M 1.54M 5.31M 1.94M 2.65M
Total operating expenses 8.38M 11.58M 16.74M 27.14M 46.07M
Cost of revenue 2.75M 2.91M 4.48M 6.25M 9.29M
Total other income expense net -0.80M -3.39M -1.49M -0.88M -0.13M
Net income from continuing ops -9.14M -16.30M -14.52M -26.63M -43.76M
Net income applicable to common shares - - - -26.63M -43.76M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 18.39M 22.29M 25.12M 35.96M 44.02M
Intangible assets - - - - 0.12M
Total liab 25.91M 23.97M 18.72M 16.63M 17.78M
Total stockholder equity -7.52M -1.68M 6.39M 19.33M 26.25M
Common stock - - - 156.34M 138.08M
Capital stock 167.01M 165.98M 161.71M 156.34M 138.08M
Retained earnings -207.85M -198.71M -182.41M -167.90M -141.27M
Other liab - - - 0.36M 1.49M
Good will - - - - 0.00M
Cash 0.15M 0.06M 0.17M 5.34M 8.86M
Total current liabilities 21.23M 21.42M 6.95M 8.07M 12.06M
Net debt 20.38M 18.21M 12.11M 1.88M -
Short long term debt 15.85M 15.71M 0.55M 0.08M 0.09M
Other stockholder equity - - - 30.89M 29.43M
Property plant equipment - - - 26.12M 30.82M
Total current assets 2.44M 3.33M 4.02M 9.20M 12.52M
Long term investments 0.23M 0.25M 0.47M 0.64M 0.57M
Net tangible assets - - - 19.33M 26.13M
Short term investments - 0.00M 0.15M 0.29M 0.75M
Net receivables 0.34M 0.23M 0.61M 0.28M 0.92M
Long term debt 4.68M 2.55M 11.73M 7.14M 3.06M
Inventory 1.50M 2.31M 2.13M 2.28M 1.25M
Accounts payable - - - 7.73M 9.11M
Non current assets total 15.96M 18.96M 21.10M 26.76M 31.51M
Capital lease obligations 0.00M 0.04M 0.31M 1.21M 1.32M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments 0.00M 0.18M -0.73M 0.23M -0.14M
Change to liabilities - - - -4.47M 9.78M
Total cashflows from investing activities - - - -1.66M -5.57M
Net borrowings 0.47M 4.63M - 4.61M 2.89M
Total cash from financing activities 2.02M 4.63M 5.30M 18.21M 23.32M
Change to operating activities - - - 0.19M 0.24M
Net income -9.14M -16.30M -14.52M -26.63M -43.76M
Change in cash 0.09M -0.13M -5.14M -3.52M -4.81M
Begin period cash flow 0.06M 0.17M 5.34M 8.86M 13.67M
End period cash flow 0.15M 0.06M 0.17M 5.34M 8.86M
Total cash from operating activities -1.97M -5.15M -9.71M -20.07M -22.56M
Issuance of capital stock - - 0.00M 13.55M 20.36M
Depreciation 1.27M 1.41M 1.58M 1.26M 1.04M
Other cashflows from investing activities - - - -0.75M -0.75M
Change to inventory 0.39M 0.75M -1.01M -3.42M -4.72M
Change to account receivables -0.13M 0.42M -0.40M 0.13M -1.99M
Other cashflows from financing activities - - - -1.28M 0.04M
Change to netincome - - - 12.88M 16.84M
Capital expenditures 0.00M 0.02M 0.52M 1.14M 5.43M
Change in working capital 0.79M 2.22M -1.62M -7.58M 3.31M
Stock based compensation 1.04M 1.54M 2.21M 6.82M 6.48M
Other non cash items 3.49M 2.04M 0.89M 3.76M 1.14M
Free cash flow -1.97M -5.17M -10.23M -21.21M -28.00M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PCLO
Pharmacielo Ltd		 -0.01
9.09%		 0.05 - 7.18 5.90 9.48 7.71 -6.50
RX
Biosyent Inc.		 0.35
2.04%		 17.50 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -0.04
2.25%		 1.96 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 -0.03
8.57%		 0.32 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 -0.01
1.61%		 0.30 20.75 - 1.88 1.89 2.85 10.19

Profile*

Pharmacielo Ltd

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. The company's products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.

82 Richmond Street East, Toronto, ON, Canada, M5C 1P1

416 315 8741

https://www.pharmacielo.com

Name Title Year Born
Mr. William Bill Petron CEO, Pres & Chairman NA
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., CMA, CPA, M.B.A., MBA CFO & Director NA
Mr. Andres Felipe Botero Chief Operating Officer NA
Mr. Marcelo Durante Global Head of Sales & Bus. Devel. NA
Dr. Decio Rabelo de Castro Filho Chief Medical Officer NA
Mr. Alex Bruvels Corp. Sec. 1988
Mr. Marc Lustig M.B.A., M.Sc. Chairman & CEO 1974
Mr. Ian D. Atacan B.Sc., C.M.A., C.P.A., M.B.A. CFO, Corporate Secretary & Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

No data available
No data available

Equity Sectors*

  • Basic Materials

    -2.34%

  • Communication Services

    +0.74%

  • Consumer Cyclical

    -2.81%

  • Consumer Defensive

    -0.87%

  • Energy

    -3.16%

  • Financial Services

    -2.32%

  • Healthcare

    -0.53%

  • Industrials

    -4.40%

  • Real Estate

    -0.43%

  • Technology

    -4.09%

  • Utilities

    -1.03%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…